Using evidence to inform decision making on health systems in LMICs: what evidence do policymakers need? Harriet Nabudere, MD, MPH Knowledge Translation.
OLE_Griffith 2_13
Achievements and results of pilot projects, results and scaling-up
Canadian Standards Association Z1000, OHS Management Systems Dave Shanahan – Project Manager.
Overview of Draft 2 (Version 4.0) ENERGY STAR Specification for Computer Monitors Craig Hershberg US EPA [email protected].
Doing Inclusion Inclusively (and using EBP to do it well) Michael S. Kelly, Ph.D. Loyola University Chicago Casper School Social Work Dept.
CDER FDA Initiatives Lilliam Rosario, Ph.D. Pharmacology/Toxicology Subcommittee on Pharmacogenomics under the Advisory Committee for Pharmaceutical Sciences.
Engagement and regulation of public health practitioners
2009- 2012 Presentation to Membership. A Recap of Our Process February 2009: Decision to renew strategic plan March 2009: Engagement of Berlin, Eaton.
III Russian – Norwegian Conference, Razvilka – Gazprom VNIIGAZ, 9th December 2010
Doing Inclusion Inclusively (and using EBP to do it well)
1 Use of Developmental Neurotoxicity data in Risk Assessment at EPA: Current Status and Future Efforts Kathleen Raffaele, EPA/OPP William Mundy, EPA/ORD.
